Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data

March 02, 2023 at 05:59 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing the data readout from an LPS human challenge trial for POLB 001, the infectious disease focused biopharma company's lead molecule.

Skillington says that he "couldn't be happier" with the results, that he says will help "ramp up the discussions" with potential partners.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-couldnt-be-happier-with-polb-001-human-challenge-trial-data-264590133

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	268.36	-3.91 (-1.44%)
AAPL	301.59	-3.32 (-1.09%)
AMD	487.69	+13.37 (2.82%)
BAC	64.66	+0.66 (1.03%)
GOOG	341.08	-1.92 (-0.56%)
META	580.52	-18.60 (-3.10%)
MSFT	492.41	-11.40 (-2.26%)
NVDA	223.58	+6.08 (2.80%)
ORCL	153.09	+7.61 (5.23%)
TSLA	326.57	-6.24 (-1.87%)

Symbol

Price

Change (%)

AMZN

268.36

-3.91 (-1.44%)

AAPL

301.59

-3.32 (-1.09%)

AMD

487.69

+13.37 (2.82%)

BAC

64.66

+0.66 (1.03%)

GOOG

341.08

-1.92 (-0.56%)

Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data

Contact Details

More News

Recent Quotes